Machine learning often feels difficult at the beginning, especially when everything stays theoretical. That changes once you start working on real projects and see how models are actually used.

Real-world evidence (RWE) has become a crucial driver of the pharmaceutical and biotechnology industries in recent years. In fact, RWE is now included in 70 percent of new drug and biologic regulatory ...